Amid these developments, Tenaya announced the departure of Leone Patterson, its Chief Financial and Business Officer, and is currently seeking a replacement. Despite this, analyst firms such as H ...

Studies conducted in human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) compared various cassette configurations and informed the final design of TN-201, which incorporates a ...

Tenaya’s Chief Executive Officer, will participate in TD Cowen’s 45 th Annual Health Care Conference and the Leerink Partners Global Healthcare Conference 2025. Details are as follows ...

the granddaughter of Chief Tenaya and the last survivor of the expulsion of the Ahwahneechees in 1851. In 1930, he persuaded his superiors to let him and two colleagues conduct a four-year survey ...

Tenaya's Board of Directors approved the repricing ... including options for the company's Chief Medical (TASE:PMCN) Officer, Whit Tingley. The company continues to make strides in its gene ...

Dosing Initiated in Cohort 2 of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Treatment of MYBPC3-Associated Hypertrophic ...

M.D., Ph.D., Tenaya’s Chief Medical Officer. “The robust transduction and improvements in cardiac function observed in a model of severe disease, provide reason to believe in TN-201’s ...